Cargando…
Targeting Histone Deacetylases: A Novel Approach in Parkinson's Disease
The worldwide prevalence of movement disorders is increasing day by day. Parkinson's disease (PD) is the most common movement disorder. In general, the clinical manifestations of PD result from dysfunction of the basal ganglia. Although the exact underlying mechanisms leading to neural cell dea...
Autores principales: | Sharma, Sorabh, Taliyan, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324954/ https://www.ncbi.nlm.nih.gov/pubmed/25694842 http://dx.doi.org/10.1155/2015/303294 |
Ejemplares similares
-
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
por: Li, Yan, et al.
Publicado: (2022) -
Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009) -
The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020) -
Targeting Huntington’s disease through histone deacetylases
por: Gray, Steven G.
Publicado: (2011) -
Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)